Showing 861 - 880 results of 64,273 for search '(( 50 ((ng decrease) OR (a decrease)) ) OR ( 5 ((mg decrease) OR (we decrease)) ))', query time: 1.06s Refine Results
  1. 861
  2. 862

    Decreased NR1 and NR2A protein expression in 21-day group. by Chenxia Han (4020017)

    Published 2017
    “…The molecular weight, based on the band size of NR1, NR2A, and β-actin were 120kDa, 170kDa, and 50kDa respectively. …”
  3. 863
  4. 864
  5. 865

    Shooting an Arrow against Convulsion: Novel Triazole-Grafted Benzenesulfonamide Derivatives as Carbonic Anhydrase II and VII Inhibitors by Mohamed A. Zeidan (21099628)

    Published 2025
    “…Evaluations of toxicity showed no neurotoxic effects and a high safety margin (LD<sub>50</sub> > 2000 mg/kg). …”
  6. 866

    Shooting an Arrow against Convulsion: Novel Triazole-Grafted Benzenesulfonamide Derivatives as Carbonic Anhydrase II and VII Inhibitors by Mohamed A. Zeidan (21099628)

    Published 2025
    “…Evaluations of toxicity showed no neurotoxic effects and a high safety margin (LD<sub>50</sub> > 2000 mg/kg). …”
  7. 867

    Shooting an Arrow against Convulsion: Novel Triazole-Grafted Benzenesulfonamide Derivatives as Carbonic Anhydrase II and VII Inhibitors by Mohamed A. Zeidan (21099628)

    Published 2025
    “…Evaluations of toxicity showed no neurotoxic effects and a high safety margin (LD<sub>50</sub> > 2000 mg/kg). …”
  8. 868

    Shooting an Arrow against Convulsion: Novel Triazole-Grafted Benzenesulfonamide Derivatives as Carbonic Anhydrase II and VII Inhibitors by Mohamed A. Zeidan (21099628)

    Published 2025
    “…Evaluations of toxicity showed no neurotoxic effects and a high safety margin (LD<sub>50</sub> > 2000 mg/kg). …”
  9. 869

    Shooting an Arrow against Convulsion: Novel Triazole-Grafted Benzenesulfonamide Derivatives as Carbonic Anhydrase II and VII Inhibitors by Mohamed A. Zeidan (21099628)

    Published 2025
    “…Evaluations of toxicity showed no neurotoxic effects and a high safety margin (LD<sub>50</sub> > 2000 mg/kg). …”
  10. 870
  11. 871

    Doxorubicin (A) and Doxorubicinol (B) concentrations in the arterial plasma following the IP administration of 1.5 or 4.5 mg kg-1 Doxorubicin. by Sergio Fabris (799604)

    Published 2015
    “…(B) Significance compared to baseline for the 1.5 mg kg-1 dose is denoted by ✝ and 4.5 mg kg-1 by *. α Denotes a decrease (P<0.05) compared to 24 hours. β Denotes difference (P<0.05) between administered doses.…”
  12. 872
  13. 873

    Image_3_A Shift in Myeloid Cell Phenotype via Down Regulation of Siglec-1 in Island Macrophages of Bone Marrow Is Associated With Decreased Late Erythroblasts Seen in Anemia of Cri... by Shirin Hasan (7894118)

    Published 2019
    “…There was only a marginal increase in the number of EBIMØ after burn, but, between the signatures of EBIMØ, Siglec-1 expression (MFI) was reduced by 40% in B with and a parallel 44% decrease in TBM erythrons in the BM. There were more (2.5-fold) EEBs and less LEBs (2.4-fold) per million TBM cells in B; with a corresponding decrease in Siglec-1 and Ly6G expressions in EBIMØ associated with EEB. …”
  14. 874

    Image_4_A Shift in Myeloid Cell Phenotype via Down Regulation of Siglec-1 in Island Macrophages of Bone Marrow Is Associated With Decreased Late Erythroblasts Seen in Anemia of Cri... by Shirin Hasan (7894118)

    Published 2019
    “…There was only a marginal increase in the number of EBIMØ after burn, but, between the signatures of EBIMØ, Siglec-1 expression (MFI) was reduced by 40% in B with and a parallel 44% decrease in TBM erythrons in the BM. There were more (2.5-fold) EEBs and less LEBs (2.4-fold) per million TBM cells in B; with a corresponding decrease in Siglec-1 and Ly6G expressions in EBIMØ associated with EEB. …”
  15. 875
  16. 876
  17. 877
  18. 878
  19. 879
  20. 880